Overland Park, Kansas based SMRxT executed a $3.9 million equity raise last week. The company has “humanized” the pill bottle to ensure that patients are taking their medicine.
The company was founded in the mid-2000s. It started as a means to improve patient adherence to medication schedule. On their website, the company estimates that this is a $300 million dollar problem that results in numerous negative effects, hospitalization and poor patient outcomes being two bad ones.
SMRxT’s system is known as NOMI. NOMI is a sensor built into a medication bottle. This sensor is able to determine how much medication is taken and at what time. In this way, “the sensor accurately measures patient adherence by medication weight, time, movement, and temperature.” (NOMI website). This data is then captured and stored in a manner that allows the patient, family, clinicians, and other interested parties to understand patient behaviors.
The founders of the company are Victor Chu and Stephan Valter, and the CEO is Michael Huffer.
For more information about the company – see their website at www.smrxt.com. Or check out the Nomi website at www.nomiadherence.com.
Thanks to our sponsor
